Innovation1 Biotech Valuation
| IVBT Stock | USD 0 0.00 0.00% |
Innovation1 Biotech seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of Innovation1 Biotech from evaluating the firm fundamentals such as Shares Owned By Insiders of 74.66 %, return on equity of -1.79, and Return On Asset of -0.0781 as well as inspecting its technical indicators and probability of bankruptcy. . In general, most investors encourage acquiring undervalued assets and selling overvalued assets since, at some point, asset prices and their ongoing real values will come together.
Overvalued
Today
Please note that Innovation1 Biotech's price fluctuation is very steady at this time. Calculation of the real value of Innovation1 Biotech is based on 3 months time horizon. Increasing Innovation1 Biotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Innovation1 otc stock is determined by what a typical buyer is willing to pay for full or partial control of Innovation1 Biotech. Since Innovation1 Biotech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Innovation1 OTC Stock. However, Innovation1 Biotech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.001 | Real 8.4E-4 | Hype 0.001 | Naive 0.001 |
The intrinsic value of Innovation1 Biotech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Innovation1 Biotech's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Innovation1 Biotech helps investors to forecast how Innovation1 otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Innovation1 Biotech more accurately as focusing exclusively on Innovation1 Biotech's fundamentals will not take into account other important factors: Innovation1 Biotech Total Value Analysis
Innovation1 Biotech is currently forecasted to have valuation of 1.83 M with market capitalization of 4.5 M, debt of 554.4 K, and cash on hands of 636.16 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Innovation1 Biotech fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.83 M | 4.5 M | 554.4 K | 636.16 K |
Innovation1 Biotech Asset Utilization
One of the ways to look at asset utilization of Innovation1 is to check how much profit was generated for every dollar of assets it reports. Innovation1 Biotech retains a negative application of resources of -0.0781 (percent), losing $7.81E-4 for each dollar of resources held by the firm. Inadequate asset utilization attests that the company is being less effective with each dollar of resources it retains. Simply put, asset utilization of Innovation1 Biotech shows how discouraging it operates for each dollar spent on its resources.Innovation1 Biotech Ownership Allocation
Innovation1 Biotech has a total of 20.02 Million outstanding shares. Innovation1 Biotech retains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 74.66 (percent) of Innovation1 Biotech outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Innovation1 Biotech Profitability Analysis
Net Loss for the year was (40.88 M) with loss before overhead, payroll, taxes, and interest of (17 K).About Innovation1 Biotech Valuation
The otc valuation mechanism determines Innovation1 Biotech's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Innovation1 Biotech based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Innovation1 Biotech. We calculate exposure to Innovation1 Biotech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Innovation1 Biotech's related companies.Innovation1 Biotech Inc. operates as a small molecule drug discovery company. The company was founded in 2014 and is based in New York, New York. Innovation1 Biotech operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.
8 Steps to conduct Innovation1 Biotech's Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Innovation1 Biotech's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Innovation1 Biotech's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Innovation1 Biotech's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Innovation1 Biotech's revenue streams: Identify Innovation1 Biotech's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Innovation1 Biotech's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Innovation1 Biotech's growth potential: Evaluate Innovation1 Biotech's management, business model, and growth potential.
- Determine Innovation1 Biotech's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Innovation1 Biotech's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Innovation1 Biotech Growth Indicators
Investing in growth stocks can be very risky. If the company such as Innovation1 Biotech does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 20 M | |
| Price Earnings Ratio | 0.0406 | |
| Retained Earnings | -44.6 M | |
| Shares Float | 2 M |
Additional Tools for Innovation1 OTC Stock Analysis
When running Innovation1 Biotech's price analysis, check to measure Innovation1 Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovation1 Biotech is operating at the current time. Most of Innovation1 Biotech's value examination focuses on studying past and present price action to predict the probability of Innovation1 Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovation1 Biotech's price. Additionally, you may evaluate how the addition of Innovation1 Biotech to your portfolios can decrease your overall portfolio volatility.